Antidepressants Trial in Parkinson's Disease

NCT03652870 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

52

Enrollment

OTHER

Sponsor class

Conditions

Depression
Parkinson Disease

Interventions

DRUG: Nortriptyline
DRUG: Escitalopram
DRUG: Placebo

Sponsor

University College, London

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]